Pathogenesis of Sjögren's syndrome: characteristics of different mouse models for autoimmune exocrinopathy.
about
Novel animal models for Sjögren's syndrome: expression and transfer of salivary gland dysfunction from regulatory T cell-deficient miceHyperosmolarity potentiates toxic effects of benzalkonium chloride on conjunctival epithelial cells in vitroVasoactive intestinal peptide inhibits TNF-alpha-induced apoptotic events in acinar cells from nonobese diabetic mice submandibular glands.Lymphocytic infiltration leads to degradation of lacrimal gland extracellular matrix structures in NOD mice exhibiting a Sjögren's syndrome-like exocrinopathyInterleukin-12 induces salivary gland dysfunction in transgenic mice, providing a new model of Sjögren's syndrome.An autoimmune response to odorant binding protein 1a is associated with dry eye in the Aire-deficient mouse.Establishment of NOD-Pdcd1-/- mice as an efficient animal model of type I diabetes.Disruption of TGF-β signaling improves ocular surface epithelial disease in experimental autoimmune keratoconjunctivitis siccaEffects of mycophenolate mofetil on proliferation and mucin-5AC expression in human conjunctival goblet cells in vitroMale NOD mouse external lacrimal glands exhibit profound changes in the exocytotic pathway early in postnatal development.Increased expression of cathepsins and obesity-induced proinflammatory cytokines in lacrimal glands of male NOD mouse.Inhibition of calcium-calmodulin kinase restores nitric oxide production and signaling in submandibular glands of a mouse model of salivary dysfunction.Sjögren's syndrome-like disease in mice with T cells lacking class 1A phosphoinositide-3-kinase.Immunoproteasome subunit LMP2 expression is deregulated in Sjogren's syndrome but not in other autoimmune disorders.Experience with experimental biological treatment and local gene therapy in Sjogren's syndrome: implications for exocrine pathogenesis and treatment.Lacrimal Gland Inflammation Deregulates Extracellular Matrix Remodeling and Alters Molecular Signature of Epithelial Stem/Progenitor Cells.Sjogrens syndrome--the non-apoptotic model of glandular hypofunction.Experimental rodent models of prostatitis: limitations and potential.Desiccating environmental stress exacerbates autoimmune lacrimal keratoconjunctivitis in non-obese diabetic miceUsefulness of mouse models to study the pathogenesis of Sjögren's syndrome.Animal models in autoimmune diseases: lessons learned from mouse models for Sjögren's syndrome.Strial microvascular pathology and age-associated endocochlear potential decline in NOD congenic mice.Altered expression of genes functioning in lipid homeostasis is associated with lipid deposition in NOD mouse lacrimal gland.Combining Sodium Hyaluronate and Polyvinylpyrrolidone Therapies for the Rabbit Cornea: A New Approach to Relief of the Human Dry Eye Syndrome.Autoimmunity against a tissue kallikrein in IQI/Jic Mice: a model for Sjogren's syndrome.Link between inflammation and aquaporin-5 distribution in submandibular gland in Sjögren's syndrome?Presence of B7-2+ dendritic cells and expression of Th1 cytokines in the early development of sialodacryoadenitis in the IqI/Jic mouse model of primary Sjörgren's syndrome.Sjogren's syndrome
P2860
Q30414128-9B0CC0C6-942B-462C-944C-AF4E39543DD0Q30513663-50B10A66-D238-4950-A54C-64CE7BD1A0C7Q33428324-B15A95E5-A4E7-459D-A8A8-DCC6E58C88BFQ33653232-071FEF3B-0BD7-438E-9FF8-058B3A2405B1Q33767896-6BDF3D07-F03D-4528-9C3F-F69D1F6D878FQ33776473-827CFFD0-216D-4FA3-BDCB-C0342F3C62AEQ33920287-D86FE4F5-2150-417A-81AA-CEE83B8E967AQ34110644-11410F90-AB9E-4604-9896-D155AC706A01Q34208099-C3550CAE-909F-4105-A6AE-514E591EA73CQ34313971-8A317234-F3B2-4B11-8339-D12F0CA52DCDQ34735358-9878E779-3FD1-40E7-8216-BA459CDC0C99Q35048426-4E527101-3258-4467-963A-B7226C6DAA7BQ35130783-B124F78C-EC41-4D38-9EF5-1754A0B34EB3Q35637495-0B75D440-C275-4E1E-A510-2823A65F3972Q35638200-69F54653-0739-4DC6-802B-EFBFFAC30702Q36425014-3C2557A3-CDFD-4B13-A5D8-6691D9993ED4Q36440848-581D50EA-A4DB-4F50-852A-73CE0F2A87AEQ36697550-E7C3FC0C-8553-4115-A0C3-4933F23B620AQ36744949-3EBE5856-58D3-4FF5-A59D-163DECA3A1D9Q36852657-83016003-EC9C-4A55-8022-F9B374AE61EBQ37016308-61D19C72-C3A1-4E4A-8549-7AE0535BCDA5Q37071828-AFE7900C-705B-4496-988A-73E229354D9DQ37288117-6C341794-33B4-4138-ACF4-0718A4420774Q39199618-E7EE0805-3847-4923-883C-3AB138C60687Q42640603-E9E70661-B0EB-4B30-89B2-CDADB9623536Q54530879-69F4E161-8A99-4C7D-976B-256B635300C4Q54748526-5F49EC3C-8D8A-4832-86B5-EDD6EA9B5FEDQ55970263-8B67855A-A2BC-4023-A808-CCACADE1B3DE
P2860
Pathogenesis of Sjögren's syndrome: characteristics of different mouse models for autoimmune exocrinopathy.
description
2002 nî lūn-bûn
@nan
2002 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Pathogenesis of Sjögren's synd ...... for autoimmune exocrinopathy.
@ast
Pathogenesis of Sjögren's synd ...... for autoimmune exocrinopathy.
@en
Pathogenesis of Sjögren's synd ...... for autoimmune exocrinopathy.
@nl
type
label
Pathogenesis of Sjögren's synd ...... for autoimmune exocrinopathy.
@ast
Pathogenesis of Sjögren's synd ...... for autoimmune exocrinopathy.
@en
Pathogenesis of Sjögren's synd ...... for autoimmune exocrinopathy.
@nl
prefLabel
Pathogenesis of Sjögren's synd ...... for autoimmune exocrinopathy.
@ast
Pathogenesis of Sjögren's synd ...... for autoimmune exocrinopathy.
@en
Pathogenesis of Sjögren's synd ...... for autoimmune exocrinopathy.
@nl
P356
P1433
P1476
Pathogenesis of Sjögren's synd ...... for autoimmune exocrinopathy.
@en
P2093
Marjan A Versnel
Saskia C A van Blokland
P304
P356
10.1006/CLIM.2002.5189
P577
2002-05-01T00:00:00Z